Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) were considered distinct from the traditional NSCLC with SMARCA4-deficient (SMARCA4-dNSCLC) in the 5th edition of the WHO classification of thoracic tumors in 2021. The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.